The trial’s primary objective is to assess PALI-2108’s tolerability, pharmacokinetics and safety in healthy volunteers.

HOUSE, PA — Third Arc Bio Inc. has administered the first dose of ARC101 to a patient in its inaugural first-in-human ...

The deal ends 2Seventy’s short run as an independent company, during which it restructured, sold off research and lost nearly ...

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will ...

The deal comes after a challenging few years for 2seventy bio, which had divested research programmes in recent years.

Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases- Lead target ...

The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered ...

Gossamer Bio ( ($GOSS) ) has released its Q4 earnings. Here is a breakdown of the information Gossamer Bio presented to its investors. Gossamer ...

Generation Bio (NASDAQ:GBIO – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Needham & Company LLC in a research note issued to investors on Friday,Benzinga reports. They ...

Finnish food technology company Onego Bio has officially purchased land within Jefferson County’s Food and Beverage ...

Trestle Bio is a preclinical stage company developing bioengineered kidney tissues for patients suffering from end stage ...

Zurcher Kantonalbank Zurich Cantonalbank decreased its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 2.8% in the 4th quarter, according to the company in its most recent Form 13F ...